Promoter swap, involving the MHC class II transactivator (CIITA) and PD‐L1, was reported in primary mediastinal B‐cell lymphoma and Hodgkin lymphoma, leading to increased PD‐L1 expression [10]. This evidence concerns the gene CIITA and B-cell non-Hodgkin lymphoma.